Author:
Hoppmann Anna L.,Dai Chen,Hageman Lindsey,Francisco Liton,Knight Jada,Mast Angela,Whelan Kimberly,Bhatia Smita,Landier Wendy
Abstract
Abstract
Purpose
Childhood cancer survivors carry a high burden of late-occurring treatment-related morbidity. Long-term risk-based anticipatory surveillance allows for early detection and management of complications. We sought to examine demographic, clinical, and social characteristics associated with survivorship clinic attendance at the Taking on Life after Cancer (TLC) Clinic at the Children’s Hospital of Alabama.
Methods
The cohort included 1122 TLC-eligible patients diagnosed with cancer between 2000 and 2016. The outcome of interest was ≥1 TLC visit. Univariable logistic regression modeling assessed cancer type, treatment era, age, sex, race/ethnicity, payer type, rural/urban residency, and distance from clinic. Significant variables (P<0.1) were retained in multivariable modeling.
Results
The median age at diagnosis was 7 years old (0–19); 47% were female, 69% non-Hispanic White, 25% African American; 45% leukemia or lymphoma, 53% solid or CNS tumor, 3% other. We found that among 1122 survivors eligible to attend a survivorship clinic in the Deep South, only 52% attended. Odds of attendance were lower among survivors diagnosed at an older age, those with cancers other than leukemia/lymphoma, those lacking private insurance, and those living farther from the clinic. Race/ethnicity and rurality were not associated with clinic attendance.
Conclusion
Just over half of eligible survivors attended survivorship clinic. Factors associated with non-attendance can be used to guide development of intervention strategies to ensure that childhood cancer survivors receive optimal long-term follow-up care.
Implications for Cancer Survivors
Measures of healthcare access (insurance status and distance to care) were identified as potential intervention targets to improve uptake of survivorship care.
Funder
University of South Carolina
Publisher
Springer Science and Business Media LLC
Reference29 articles.
1. Surveillance, Epidemiology, and End Results, Program, SEER Cancer Statistics Review 1975-2018. Updated April 15, 2021. Accessed March 27, 2024]; Available from: https://seer.cancer.gov/csr/1975_2018/.
2. Hudson MM, et al. Clinical ascertainment of health outcomes among adults treated for childhood cancer. JAMA. 2013;309(22):2371–81.
3. Dixon SB, et al. Specific causes of excess late mortality and association with modifiable risk factors among survivors of childhood cancer: a report from the Childhood Cancer Survivor Study cohort. Lancet. 2023;401(10386):1447–57.
4. Landier W, et al. Surveillance for late effects in childhood cancer survivors. J Clin Oncol. 2018;36(21):2216–22.
5. Robison LL, Hudson MM. Survivors of childhood and adolescent cancer: life-long risks and responsibilities. Nat Rev Cancer. 2014;14(1):61–70.